191 related articles for article (PubMed ID: 22297506)
21. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
22. A computer-aided diagnostic system to discriminate SPIO-enhanced magnetic resonance hepatocellular carcinoma by a neural network classifier.
Guo D; Qiu T; Bian J; Kang W; Zhang L
Comput Med Imaging Graph; 2009 Dec; 33(8):588-92. PubMed ID: 19656655
[TBL] [Abstract][Full Text] [Related]
23. Are all these HCCs incidental? Think again!
Altraif I
Gastroenterology; 1997 Aug; 113(2):730. PubMed ID: 9247499
[No Abstract] [Full Text] [Related]
24. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.
Bartolozzi C; Battaglia V; Bozzi E
Abdom Imaging; 2011 Jun; 36(3):290-9. PubMed ID: 21267561
[TBL] [Abstract][Full Text] [Related]
25. Imaging of hepatocellular carcinoma and early diagnosis.
Limaye AR; Cabrera R
Minerva Med; 2010 Dec; 101(6):395-404. PubMed ID: 21196899
[TBL] [Abstract][Full Text] [Related]
26. [The recent progress of MRI].
Nawano S; Nasu K; Murakami K; Kuroki Y; Fujikawa H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():288-91. PubMed ID: 11761958
[No Abstract] [Full Text] [Related]
27. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
28. LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas.
Jha RC; Mitchell DG; Weinreb JC; Santillan CS; Yeh BM; Francois R; Sirlin CB
AJR Am J Roentgenol; 2014 Jul; 203(1):W48-69. PubMed ID: 24951229
[TBL] [Abstract][Full Text] [Related]
29. CT and MRI findings of cirrhosis-related benign nodules with ischaemia or infarction after variceal bleeding.
Kim YK; Park G; Kim CS; Han YM
Clin Radiol; 2010 Oct; 65(10):801-8. PubMed ID: 20797466
[TBL] [Abstract][Full Text] [Related]
30. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional display of liver, spleen, hepatoma, and blood vessels by MR imaging and computer graphics.
Kashiwagi T; Murakami T; Azuma M; Tamaki J; Ishibashi K; Kishida Y; Takei Y; Kawano S; Fusamoto H; Kamada T
Acta Radiol; 1994 Jan; 35(1):88-9. PubMed ID: 8305281
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
[TBL] [Abstract][Full Text] [Related]
33. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma and other hepatic malignancies: MR imaging.
Roth CG; Mitchell DG
Radiol Clin North Am; 2014 Jul; 52(4):683-707. PubMed ID: 24889167
[TBL] [Abstract][Full Text] [Related]
35. Imaging of hepatocellular carcinoma: practical guide to differential diagnosis.
Anis M; Irshad A
Clin Liver Dis; 2011 May; 15(2):335-52, vii-x. PubMed ID: 21689617
[TBL] [Abstract][Full Text] [Related]
36. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
37. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging in cirrhosis: what's new?
Barr DC; Hussain HK
Top Magn Reson Imaging; 2014 Apr; 23(2):129-49. PubMed ID: 24690617
[TBL] [Abstract][Full Text] [Related]
39. MR imaging of hepatocellular carcinoma.
Onaya H; Itai Y
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):757-68. PubMed ID: 11149678
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
